Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. B Cell Biology

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1647209

Toll-like receptor 7/8 agonist stimulation rapidly skews the antibody repertoire of B cells in non-human primates

Provisionally accepted
Shiyu  WangShiyu Wang1Yifei  WuYifei Wu2Yuting  XuYuting Xu1Rui  DengRui Deng2Fangzheng  LiuFangzheng Liu2Michael  CitronMichael Citron3Lihua  LuoLihua Luo4I-Ming  WangI-Ming Wang3Xiao  LiuXiao Liu5Wei  ZhangWei Zhang2*
  • 1Department of cell biology and neurology, School of Life Sciences, Xuzhou Medical University, Xuzhou, China
  • 2Department of Biomedical Informatics, School of Life Sciences, Central South University, Changsha, China
  • 3Merck & Co. Inc., Kenilworth, United States
  • 4BGI Group, Shenzhen, China
  • 5Tsinghua University, Beijing, China

The final, formatted version of the article will be published soon.

Toll-like receptors 7 and 8(TLR7/8) recognize purine-rich single-stranded RNA from pathogens, triggering immune responses. Although TLR7/8 agonists are emerging as potential novel adjuvants, their impact on the adaptive B cell response, particularly antibody repertoire, remains unclear. Here, six Indian rhesus macaques(IRMs) and six African green monkeys(AGMs) were stimulated with a TLR7/8 agonist. Peripheral blood samples were collected pre-stimulation and multiple timepoints within one week post-stimulation for flow cytometry and antibody repertoire sequencing. B cell activation was observed at 24 hours. Significant increases in antibody repertoire diversity were detected at 48 and 72 hours in both species; however, diversity remained elevated at one week in IRMs but returned to baseline in AGMs. Analysis of antibody lineage distributions revealed a marked increase in increased lineages at 48 and 72 hours, characterized by higher frequency, a greater number of antibody clonotypes, and increased mutation rates. The identified expanded lineages, induced by the TLR7/8 agonist, exhibited λ chain bias and divergent antibodies across individuals, and primarily originated from highly mutated antibodies, likely corresponding to memory/effector-like B cells. Our findings demonstrate that the TLR7/8 agonist rapidly induces a divergent expansion of B cells, establishing an immune foundation supporting vaccine responses and offering new insights into the dynamic B cell modulation.

Keywords: Toll-like receptor 7 and 8 agonist, Antibody repertoire, adjuvant development, non-human primates, B cells

Received: 15 Jun 2025; Accepted: 28 Aug 2025.

Copyright: © 2025 Wang, Wu, Xu, Deng, Liu, Citron, Luo, Wang, Liu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Wei Zhang, Department of Biomedical Informatics, School of Life Sciences, Central South University, Changsha, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.